These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22461703)

  • 41. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
    Bell CJ; Sun Y; Nowak UM; Clark J; Howlett S; Pekalski ML; Yang X; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Umana P; Klein C; Hosse RJ; Wicker LS; Peterson LB
    J Autoimmun; 2015 Jan; 56():66-80. PubMed ID: 25457307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.
    Oliveira PR; Dessein H; Romano A; Cabantous S; de Brito ME; Santoro F; Pitta MG; Pereira V; Pontes-de-Carvalho LC; Rodrigues V; Rafati S; Argiro L; Dessein AJ
    J Immunol; 2015 Mar; 194(6):2664-72. PubMed ID: 25672756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
    Soper DM; Kasprowicz DJ; Ziegler SF
    Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis.
    Murawski MR; Litherland SA; Clare-Salzler MJ; Davoodi-Semiromi A
    Ann N Y Acad Sci; 2006 Oct; 1079():198-204. PubMed ID: 17130555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional Modulation of Regulatory T Cells by IL-2.
    Moon BI; Kim TH; Seoh JY
    PLoS One; 2015; 10(11):e0141864. PubMed ID: 26529512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-33 Effect on Quantitative Changes of CD4
    Ryba-Stanisławowska M; Werner P; Skrzypkowska M; Brandt A; Myśliwska J
    Mediators Inflamm; 2016; 2016():9429760. PubMed ID: 27761063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3.
    Hillebrands JL; Whalen B; Visser JT; Koning J; Bishop KD; Leif J; Rozing J; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2006 Dec; 177(11):7820-32. PubMed ID: 17114453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MKL-1 is a coactivator for STAT5b, the regulator of Treg cell development and function.
    Xiang Y; Wang J; Li JP; Guo W; Huang F; Zhang HM; Li HH; Dai ZT; Zhang ZJ; Li H; Bao LY; Gu CJ; Chen K; Zhang TC; Liao XH
    Cell Commun Signal; 2020 Jul; 18(1):107. PubMed ID: 32646440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of FOXP3
    Mohr A; Atif M; Balderas R; Gorochov G; Miyara M
    Clin Exp Immunol; 2019 Jul; 197(1):24-35. PubMed ID: 30830965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CXCL4 promoted the production of CD4
    Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
    Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
    [No Abstract]   [Full Text] [Related]  

  • 52. CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells.
    Ding Y; Yu A; Tsokos GC; Malek TR
    J Immunol; 2019 Jul; 203(1):93-104. PubMed ID: 31085588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases.
    Ohkura N; Sakaguchi S
    Cell Res; 2020 Jun; 30(6):465-474. PubMed ID: 32367041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pre-diagnostic genotyping identifies T1D subjects with impaired Treg IL-2 signaling and an elevated proportion of FOXP3
    Marwaha AK; Panagiotopoulos C; Biggs CM; Staiger S; Del Bel KL; Hirschfeld AF; Priatel JJ; Turvey SE; Tan R
    Genes Immun; 2017 Jan; 18(1):15-21. PubMed ID: 28053319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extension of the CD4⁺Foxp3⁺CD25(-/low) regulatory T-cell subpopulation in type 1 diabetes mellitus.
    Zóka A; Barna G; Somogyi A; Műzes G; Oláh Á; Al-Aissa Z; Hadarits O; Kiss K; Firneisz G
    Autoimmunity; 2015; 48(5):289-97. PubMed ID: 25523632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.
    Rosenzwajg M; Churlaud G; Mallone R; Six A; Dérian N; Chaara W; Lorenzon R; Long SA; Buckner JH; Afonso G; Pham HP; Hartemann A; Yu A; Pugliese A; Malek TR; Klatzmann D
    J Autoimmun; 2015 Apr; 58():48-58. PubMed ID: 25634360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
    Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
    PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies.
    Chistiakov DA; Voronova NV; Chistiakov PA
    Immunol Lett; 2008 Jun; 118(1):1-5. PubMed ID: 18417224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.